Clik here to view.
LabCorp to Acquire Assets of Mount Sinai Health System Clinical Outreach...
Tuesday, January 10th 2017 at 1:30pm UTC Transaction will benefit physicians and patients in metropolitan New York City BURLINGTON, N.C.–(BUSINESS WIRE)– Laboratory Corporation of America® Holdings...
View ArticleClik here to view.
venBio Sends Letter to Immunomedics Stockholders
Wednesday, January 11th 2017 at 2:00pm UTC Believes Change is Urgently Needed to Build Sustained Stockholder Value and Correct String of Strategic Missteps Cites Company’s Failure to Meaningfully...
View ArticleClik here to view.
venBio Sends Letter to Immunomedics Stockholders
Wednesday, January 18th 2017 at 8:02pm UTC Criticizes Immunomedics’ Recent Disingenuous and Misleading Statements Urges Stockholders to Support Meaningful Change and Put in Place Experienced and...
View ArticleClik here to view.
RenovaCare: 2017 Shareholder Update
Tuesday, January 17th 2017 at 2:15pm UTC NEW YORK & PITTSBURGH–(BUSINESS WIRE)– RenovaCare, Inc., (OTCQB:RCAR), developer of the patented CellMist™ and SkinGun™ technologies* for isolating and...
View ArticleClik here to view.
CORRECTING and REPLACING venBio Sends Letter to Immunomedics Stockholders
Wednesday, January 18th 2017 at 10:20pm UTC Criticizes Immunomedics’ Recent Disingenuous and Misleading Statements Urges Stockholders to Support Meaningful Change and Put in Place Experienced and...
View ArticleClik here to view.
Synergy Pharmaceuticals’ TRULANCE™ (Plecanatide) Receives U.S. FDA Approval...
Thursday, January 19th 2017 at 11:35pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced today that the U.S. Food and Drug Administration (FDA) has approved TRULANCE™...
View ArticleClik here to view.
Baxter to Present at the 6th Annual Leerink Partners Global Healthcare...
Thursday, January 19th 2017 at 9:15pm UTC DEERFIELD, Ill.–(BUSINESS WIRE)– Baxter International Inc. (NYSE: BAX) will present at the 6th Annual Leerink Partners Global Healthcare Conference on...
View ArticleClik here to view.
Bristol-Myers Squibb and Ono Pharmaceutical Company Enter Settlement and...
Friday, January 20th 2017 at 9:01pm UTC Merck to pay Bristol-Myers Squibb and Ono royalties on global sales of Keytruda through 2026, and lump-sum payment of $625 million Ends all global...
View ArticleClik here to view.
Cellectis Studies Safety in New CAR Architecture Controlling CAR T-Cell...
Monday, January 23rd 2017 at 6:00am UTC Publication in Scientific Reports, a Nature Publishing Group Journal NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS), a...
View ArticleClik here to view.
Cellectis: Four Prominent Physicians to Join Cellectis Clinical Advisory Board
Monday, January 23rd 2017 at 9:30pm UTC New Board Members Include Professors John Gribben, Koen van Besien, Kanti Rai and Catherine Thieblemont NEW YORK–(BUSINESS WIRE)– class= »bwalignl »>...
View ArticleClik here to view.
2016 Industry Pressures Drive Mixed Healthcare Investor Sentiment in 4th Quarter
Tuesday, January 24th 2017 at 1:00pm UTC IPO values jump; deal and financing volumes up but values down:BioPharm Insight 4Q Financing, Licensing and M&A Report NEW YORK–(BUSINESS WIRE)– Although...
View ArticleClik here to view.
Global Myasthenia Gravis Drugs Market – Analysis, Technologies & Forecasts to...
Wednesday, January 25th 2017 at 2:09pm UTC DUBLIN–(BUSINESS WIRE)– Research and Markets has announced the addition of the « Global Myasthenia Gravis Drugs Market 2017-2021″ report to their offering....
View ArticleClik here to view.
Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results
Thursday, January 26th 2017 at 11:59am UTC Increases Fourth Quarter Revenues 22% to $5.2 Billion, 17% for Full Year to $19.4 Billion Posts Fourth Quarter GAAP EPS of $0.53 and Non-GAAP EPS of $0.63...
View ArticleClik here to view.
venBio Releases Presentation Detailing Urgent Case for Change at Immunomedics
Thursday, January 26th 2017 at 1:00pm UTC Outlines Strategic Plan to Maximize Value and Improve Corporate Governance Reveals Interconnectedness of Newly-Appointed Immunomedics Board and Lack of...
View ArticleClik here to view.
Pfizer Announces Positive Top-Line Results from Phase 2 Study of...
Thursday, January 26th 2017 at 1:00pm UTC Pfizer’s C. difficile Vaccine Candidate to Commence Phase 3 Study in First Half of 2017 C. difficile is an Increasing Worldwide Concern Associated with...
View ArticleClik here to view.
Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib...
Friday, January 27th 2017 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
View ArticleClik here to view.
CELGENE OBTIENT L’AVIS FAVORABLE DU COMITÉ DES MÉDICAMENTS À USAGE HUMAIN...
Friday, January 27th 2017 at 12:18pm UTC REVLIMID® est le premier médicament à recevoir un avis favorable du CHMP pour le traitement d’entretien du myélome multiple non préalablement traité chez les...
View ArticleClik here to view.
Poxel Announces Fourth Quarter 2016 Financial Update
Friday, January 27th 2017 at 7:00am UTC LYON, France–(BUSINESS WIRE)– POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for...
View ArticleClik here to view.
Celgene Receives Positive CHMP Opinion to Expand REVLIMID® (Lenalidomide)...
Friday, January 27th 2017 at 12:17pm UTC REVLIMID® is the first and only medicine granted positive CHMP opinion for post-Autologous Stem Cell Transplantation (ASCT) maintenance therapy in MM The new...
View ArticleClik here to view.
REVLIMID® (lenalidomida) recibe la opinión positiva del CHMP como terapia de...
Friday, January 27th 2017 at 12:18pm UTC Tras su aprobación por la Agencia Europea, lenalidomida sería el primer y único tratamiento de mantenimiento autorizado para este grupo de pacientes....
View Article